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Exposure of vitamins to UVB and UVA radiation
generates singlet oxygen
Alena Knak, Johannes Regensburger, Tim Maisch and Wolfgang Bäumler*
Deleterious eﬀects of UV radiation in tissue are usually attributed to diﬀerent mechanisms. Absorption of
UVB radiation in cell constituents like DNA causes photochemical reactions. Absorption of UVA radiation
in endogenous photosensitizers like vitamins generates singlet oxygen via photosensitized reactions. We
investigated two further mechanisms that might be involved in UV mediated cell tissue damage. Firstly,
UVB radiation and vitamins also generate singlet oxygen. Secondly, UVB radiation may change the chemical
structure of vitamins that may change the role of such endogenous photosensitizers in UVA mediated
mechanisms. Vitamins were irradiated in solution using monochromatic UVB (308 nm) or UVA (330, 355,
or 370 nm) radiation. Singlet oxygen was directly detected and quantiﬁed by its luminescence at 1270 nm.
All investigated molecules generated singlet oxygen with a quantum yield ranging from 0.007 (vitamin D3)
to 0.64 (nicotinamide) independent of the excitation wavelength. Moreover, pre-irradiation of vitamins
with UVB changed their absorption in the UVB and UVA spectral range. Subsequently, molecules such as
vitamin E and vitamin K1, which normally exhibit no singlet oxygen generation in the UVA, now produce
singlet oxygen when exposed to UVA at 355 nm. This interplay of diﬀerent UV sources is inevitable when
applying serial or parallel irradiation with UVA and UVB in experiments in vitro. These results should be of
particular importance for parallel irradiation with UVA and UVB in vivo, e.g. when exposing the skin to
solar radiation.
Introduction
Radiation of the ultraviolet spectral range is known to be
hazardous to human health by inducing inflammation, catar-
act formation in the eye, premature skin aging and skin
cancer.1,2 In the US, skin cancer is the most frequent cancer
showing an incidence of about 40 percent of all diagnosed
human cancers.3 The interaction of UV radiation with tissue
depends on its wavelength. UV radiation is divided into UVC
(<280 nm), UVB (280–320 nm) and UVA (320–400 nm) radi-
ation. UVC radiation is almost completely absorbed in the
atmosphere. UVB and UVA radiation is only partially absorbed
in the atmosphere. Therefore solar radiation on the earth com-
prises UVA (∼95%) and UVB (∼5%).4 The UVA spectrum is sub-
divided depending on the wavelength into UVA2 (320–340 nm)
and UVA1 (340–400 nm), which is based on biological eﬀects
such as solar-UV-signature mutations in mouse skin5 and on
skin eﬀects in phototherapy.6 Up to 50% of UVA can reach the
depth of melanocytes and the dermal compartment, whereas
14% of UVB reaches the lower epidermis.4
It is commonly accepted that UVB radiation is directly
absorbed in cellular DNA, which typically leads to the for-
mation of cyclobutane pyrimidine dimers (CPD) and pyrimi-
dine(6-4)pyrimidone photoproducts (6-4PP).7 Since UVA is only
poorly absorbed by DNA or proteins, other molecules in tissue
may absorb that radiation. In case such a molecule can act as
an endogenous photosensitizer, energy or charge transfer may
occur from its triplet T1 state to other adjacent molecules yield-
ing reactive oxygen species (ROS), in particular singlet oxygen
(1O2).
8–10 The deleterious biological eﬀects of UVA radiation
are mediated by these ROS; among them, 1O2 plays a major
role.11–14
A number of endogenous UVA-photosensitizers have been
identified in the past few decades. Among them, some vita-
mins of the A and B group, as well as medical drugs, play a
major role.10 Being regularly present in cells of tissue, which
are frequently exposed to UV radiation, vitamins are potential
photosensitizers and targets of UV radiation induced cell
damage in the skin and eyes.
Vitamins are organic chemical compounds, which are
essential for most organisms but cannot be produced in
suﬃcient quantities by the organism,15,16 and are taken up
with the diet.16,17 Humans need diﬀerent aqueous and lipo-
soluble vitamins because of their important role as cofactors
or coenzymes in human metabolism reactions.17,18 One of the
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most important benefits claimed for vitamins A, C, E and
many of the carotenoids is their role as antioxidants, which
are scavengers of free radicals, in particular when synergistic
eﬀects occur.19 However, some vitamins such as B3, D2, D3,
and E were not considered as endogenous UVA-photosensiti-
zers because these molecules do not absorb UVA radiation.
From a photophysical point of view, the photosensitized
generation of 1O2 should also be possible with UVB radiation,
in particular because many known endogenous UVA-photosen-
sitizers also absorb UVB radiation, even to a higher extent than
UVA radiation (Fig. 1). Thus, UVB induced 1O2 might play an
additional, important role in the mechanisms of oxidative
tissue damage. However, this has rarely been investigated in
the past few decades.20–22 Vitamin E (α-tocopherol) was found
to generate 1O2 under UVB-irradiation, and its functional
eﬃciency as an antioxidant is now under discussion.20 As a
first step, we recently found that riboflavin, pyridoxine hydro-
chloride, and nicotinic acid produced 1O2 with a yield of
0.05 to 0.40 when exposed to 308 nm (UVB).23
In the present study, we firstly investigated the 1O2 gen-
eration of a series of vitamins17,24 (Fig. 1) when exposed to
UVB radiation. Secondly, the molecular structure may change
when vitamins are exposed to UVB. This in turn may lead to a
change of the absorption coeﬃcient of such molecules in the
entire range of ultraviolet radiation and hence change the
ability to generate 1O2.
23 Therefore, we pre-irradiated the
vitamins with UVB and determined subsequently the quantum
yield of 1O2 generation for UVA radiation.
Materials and methods
Chemicals
5,10,15,20-Tetrakis(N-methyl-4-pyridyl)-21H,23H-porphine
(TMPyP), sulfonated perinaphthenone (PNS) and perinaphthe-
none (PN) were used as reference photosensitizers to deter-
mine 1O2 quantum yield of the endogenous vitamins. TMPyP
and PNS are well soluble in aqueous solutions like water (H2O)
and deuterium oxide (D2O) with
1O2 quantum yields of 0.77 ±
0.0424 or close to unity.25 PN is well soluble in ethanol solution
with a 1O2 quantum yield of 0.93 ± 0.08.
26 As aqueous soluble
vitamins riboflavin, riboflavin 5′monophosphate sodium salt
hydrate (FMN), flavin adenin dinucleotide (FAD), nicotinic
acid, nicotinamide, pyridoxine (PYR), pyridoxine hydrochlo-
ride (PYR-HCL), pyridoxamine dihydrochloride (PYRINE-
DHCL), pyridoxal hydrochloride (PYRXAL-HCL) and pyridoxal
5′phosphate hydrate (PYR-5-PH) were investigated. All these
vitamins were dissolved preferably in H2O or D2O with
diﬀerent concentrations to achieve an appropriate absorption
at the excitation wavelength between 30% and 80% using
a cuvette with 1 cm thickness. The choice of aqueous solvent
depended on the signal intensity of 1O2 luminescence. As lipo-
philic vitamins retinal all-trans (vitamin A), ergocalciferol
(vitamin D2), cholecalciferol (vitamin D3), DL-α-tocopherol
(vitamin E) and phyllochinon (vitamin K1) were investigated.
All these substances were solved in ethanol under the same
conditions as the aqueous soluble substances. All substances
were purchased from Sigma-Aldrich, Steinheim, Germany,
except PN (Acros Organics, Geel, Belgium) and PNS, nicotinic
acid and nicotinamide (Institute of Organic Chemistry, Univer-
sity of Regensburg, Germany).
Absorption spectra
The transmission spectra of each solution probe were
measured with a one-beam spectrophotometer (DU640,
Beckman Instruments GmbH, Munich, Germany) using a
quartz cuvette with an optical path of 1 cm (QS-101, Hellma
Optik, Jena, Germany). The absorption values were calculated
as A = 100% − T, where T is the transmission value.
Oxygen concentration
The oxygen concentration in solution was measured in a
quartz cuvette with a needle sensor (MICROX TX, PreSens
GmbH, Regensburg, Germany).
Luminescence experiments
The solutions of the diﬀerent molecules were transferred into
a cuvette (QS-101, Hellma Optik, Jena, Germany) and excited
by using a tunable laser system which is based on a Nd:YAG
pump laser, with a pulse energy smaller than 3.15 mJ, a pulse
duration of 7 ns and a repetition rate of 1 kHz. The laser emis-
sion is continuously tunable from 210 to 2600 nm, but for theFig. 1 The molecular structures of the investigated vitamins.
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experiments excitation wavelengths in the UVB (308 nm) and
UVA (330, 355, 370 nm) ranges were used. The laser intensity,
which reaches the cuvette, depends on the wavelength and
ranged in the experiments between 15 and 50 mW cm−2. The
1O2 luminescence (1270 nm) was detected using a photomulti-
plier (R5509-42, Hamamatsu Photonics Deutschland GmbH,
Herrsching, Germany).27 For spectral resolution, luminescence
was detected at wavelengths from 1150 to 1350 nm by using
interference filters in front of the photomultiplier.
Spectrally resolved 1O2 luminescence
The total sum of all detected luminescence photons is calcu-
lated at the detected wavelengths given by the respective inter-
ference filters. A curve was fitted (Lorentz-shape) to the sum of
the single values. The values are normalized to the maximum
of the curve.
Determination of 1O2 luminescence decay and rise time
The decay and rise time of the 1O2 luminescence signal are
given by the following formula:28,29
IðtÞ ¼ C
τR1  τR1 exp 
t
τD
 
 exp  t
τR
  
ð1Þ
The constant C was used to fit the luminescence signal
(Mathematica 8.0, Wolfram Research, Berlin, Germany) yield-
ing the decay and rise times (tD, tR). The experimental accuracy
was estimated to be between 10 and 20% of the value deter-
mined by the fit.
Determination of the 1O2 quantum yield
To estimate the quantum yield of the analyzed endogenous
molecules, the measured luminescence signals were compared
to the signals of the respective reference photosensitizer with
known quantum yield ΦΔ. The quantum yields of aqueous
soluble molecules were compared to the quantum yields of
PNS and TMPyP and the quantum yield of ethanol soluble
molecules to PN and TMPyP. The endogenous molecule and
the reference photosensitizer were dissolved in the corres-
ponding solvent in diﬀerent concentrations. Because the
oxygen concentration has an influence on the quantum yields
for all measurements, air saturated solutions were used. First
the absorption of the diﬀerent solutions at the excitation wave-
length (EW) was calculated to determine the absorbed energy
Eabs of each substance with the laser power at the EW. Then
the 1O2 luminescence signals were measured for diﬀerent con-
centrations of the endogenous molecule and the reference sub-
stance at the EW. The sum of all 1O2 luminescence photons
was used to estimate the luminescence energy Elum.
Using reference photosensitizers, the quantum yield Φ?Δ
was calculated by comparing the slopes S of the luminescence
energy Elum of the
1O2 luminescence (unknown or reference)
versus the absorbed laser energy Eabs with the following
formula:28
S?ð½O2Þ
Srefð½O2Þ ¼
Φ?Δð½O2Þ
ΦrefΔ ð½O2Þ
ð2Þ
Photostability
For investigating the photostability of the vitamins in the UVB
range, a broadband UVB Transluminator (FLX-20M Translumi-
nator, Biometra GmbH, Göttingen, Germany) was used. The
UVB tubes of the Transluminator have an emission maximum
at 312 nm and the cuvettes could be irradiated equally from
one side with a specific UVB radiant exposure (J cm−2).
Results and discussion
Vitamins are essential compounds for many functions of the
human organism including the skin. Some vitamins can be
synthesized, but others need to be obtained by an adequate
diet. In addition, vitamins are applied topically for skin care
and to treat skin diseases. The human epidermis contains sig-
nificant amounts of vitamin A (all-trans-retinol), enzymes
responsible for its metabolism, binding proteins for its protec-
tion and transport, and the nuclear receptors involved in the
respective induced gene activity modulation. Vitamin A nor-
malizes keratinization and can be topically applied to treat
acne or photodamage of the skin.30–32 Vitamin E, like vitamin
A, is present in mammalian skin. The probable physiological
function of epidermal vitamin E is to contribute to the anti-
oxidant defense of the skin, usually in combination with
vitamin C.
Vitamin B3, or nicotinamide or niacinamide, is a derivative
of niacin obtained through diet from meat, fish, milk, eggs,
and nuts. Nicotinamide is part of the coenzymes nicotinamide
adenine dinucleotide (NAD), NAD phosphate (NADP), and its
reduced forms are NADH and NADPH. Clinical studies have
presented results on its anti-inflammatory actions. Nicotina-
mide is responsible for the synthesis of sphingolipids, free
fatty acids, cholesterol, and ceramides, thus decreasing trans-
epidermal water loss.
Vitamin C is a very important antioxidant in human skin.
However, even extensive oral supplementation leads to a
limited increase of vitamin C in skin only. Therefore, topical
application of vitamin C is an appropriate way to increase its
concentration in the skin. Vitamin C supports the formation
of stratum corneum barrier lipids and regenerates vitamin
E. Vitamin K displays antihemorrhagic properties and topical
application of vitamin K has been used for the prevention of
vascular manifestations of aging, for the suppression of pig-
mentation and for the resolution of bruising.
Solar radiation is the major source of UV radiation that
interacts with cells of the skin and eye and can be absorbed by
vitamins present in such cells. For example, UV is important
for the synthesis of vitamin D3 but at the same time, vitamins
and UV can aﬀect the integrity of the skin and eye lens via
photosensitized production of 1O2. This reactive oxygen
species can yield products like 8-oxo-7,8-dihydro-2′-deoxygua-
nosine (8oxodGuo).4,11,33,34 This conflicting potential of vita-
mins was already known for some substances in correlation
with UVA radiation. Many vitamins show high absorption
values in the UVB range 280–320 nm compared to the UVA
Paper Photochemical & Photobiological Sciences
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(320–400 nm) range. Fig. 2 shows the absorption spectra of
investigated vitamins from 280–400 nm. The substances were
dissolved with an appropriate concentration to provide absorp-
tion values between 20 and 80% when excited in the UVB
(308 nm). The high UVB absorption of vitamins is an excellent
prerequisite for photosensitized production of 1O2 that was
subsequently measured.
1O2 luminescence detection of vitamins excited at 308 nm
The aqueous soluble vitamins FAD (150 µM), FMN (200 µM),
riboflavin (200 µM), PYR-5-PH (100 µM), PYRXAL-HCL
(100 µM), PYRINE-DHCL (100 µM), PYR-HCL (100 µM), PYR
(100 µM), nicotinic acid (30 mM) and nicotinamide (30 mM)
were dissolved in D2O and excited at 308 nm. The lipophilic
vitamin A (30 µM), vitamin D2 (250 µM), vitamin D3 (250 µM),
vitamin E (250 µM) and vitamin K1 (100 µM) were dissolved in
ethanol and also excited at 308 nm.
All substances revealed clear time- and spectrally resolved
1O2 luminescence signals, exemplarily shown for FMN (Fig. 3).
The substances FMN, riboflavin, nicotinic acid and nicotina-
mide showed luminescence decay times in the range of 65 to
67 µs, which corresponds well with the 1O2 decay time in D2O
(66 µs).35 PYR-5-PH, PYRXAL-HCL, PYRINE-DHCL, PYR-HCL
and PYR solutions yielded luminescence decay times in the
range of 46 to 54 µs, which is clearly shorter than the 1O2
decay time in D2O, but in agreement with the results of Dzha-
garov et al. for vitamin B6.
36 This shortening of 1O2 decay time
is mainly caused by quenching of 1O2 decay by the photosensi-
tizer molecule itself (self-quenching).37 PYR-5-PH, PYR-
XAL-HCL, PYRINE-DHCL, PYR-HCL and PYR are all known 1O2
quenchers.38 This eﬀect was more pronounced for FAD, which
showed a decay time of about 28 µs.
Concerning the lipophilic vitamins, the fitted decay of
vitamin A in ethanol was 14 µs, which corresponds well to the
1O2 decay time in this solvent.
39 For vitamin E the fitted decay
time was about 9 µs, which is considerably shorter than the
1O2 decay time in ethanol. This is probably due to the fact that
vitamin E is a good quencher of 1O2.
40 The luminescence
signals of vitamin D2, D3 and K1 were too weak to fit rise and
decay times (eqn (1)).
Fig. 2 The measured absorption spectra of the diﬀerent investigated
vitamins are shown in the UVB and UVA range (280–400 nm). The vita-
mins were dissolved in aqueous solution (A, B) or ethanol (C) and the
absorption spectra were measured without any further irradiation.
Fig. 3 The time-resolved 1O2 signal of 200 µM FMN in D2O is shown
together with the ﬁtted decay and rise times (bottom). On the top the
respective spectral resolution for FMN is shown with a clear peak
between 1270 and 1280 nm.
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The oxygen concentration in solution decreased for some
vitamins during irradiation (308 nm, 35 mW). After
20 minutes, the maximum decrease was found in solutions of
vitamin E (88.5%) and vitamin K1 (40.2%). The percentage
values represent the decrease with reference to the initial value
before irradiation. The B6 vitamins and vitamin A showed a
decrease of oxygen concentration in the range of 7.0 to 35.0%.
Nicotinamide and vitamin D2 showed a decrease of 2.0% and
10.0%, respectively, whereas nicotinic acid and vitamin D3
showed no decrease within experimental accuracy. This sup-
ports the assumption that these molecules may react with 1O2
being a generator and a quencher of 1O2 at the same time.
The spectrally resolved luminescence signals of the
aqueous soluble vitamins showed a maximum in the range of
1269 to 1277 nm, which is in line with the transition energy of
the excited (1O2) to the ground state (
3O2) of oxygen in aqueous
solvents.37 The spectrally resolved 1O2 luminescence signal of
the lipophilic vitamins had a maximum at 1274 ± 2 nm, which
is likewise in line with the transition energy of oxygen in
ethanol.39 Since all experiments show this spectrally resolved
maximum of luminescence, the detected signals clearly
provide evidence of 1O2 production of these vitamins when
excited with UVB.
Quantum yield of 1O2 generation
The eﬃcacy of 1O2 generation of a specific photosensitizer
(ΦΔ) critically depends on the intersystem crossing quantum
yield of the photoexcited molecule and on the eﬃciency of
energy transfer to oxygen. The values of ΦΔ were measured for
all vitamins in solution at 308 nm (UVB). The well-known
photosensitizers PNS and TMPyP were used as reference for
aqueous soluble vitamins and PN and TMPyP served as refer-
ence for lipophilic vitamins. All aqueous soluble vitamins were
dissolved in H2O at diﬀerent concentrations, except nicotinic
acid and nicotinamide, which were dissolved in D2O to achieve
suﬃciently high luminescence signals. The lipophilic vitamins
were dissolved in ethanol at diﬀerent concentrations. The
1O2 luminescence decay time of all vitamins and reference
photosensitizers was either 3.5 ± 0.4 µs (H2O) or in the range
of 65 to 67 µs (D2O).
Quantum yield of 1O2 generation using UVB excitation
We recently investigated a small number of bio-molecules
regarding 1O2 generation under UVB radiation.
23 Besides some
fatty acids, riboflavin, PYR-HCL, and nicotinic acid generated
1O2 when exposed to 308 nm. Now, we could extend the list of
endogenous UVB photosensitizers and show that all investi-
gated vitamins exhibit a quantum yield for 1O2 generation
when exposed to UVB radiation at 308 nm. As displayed in
Table 1, the values ranged from 0.007 ± 0.005 for vitamin D3 to
0.64 ± 0.07 for nicotinamide. Among the investigated vitamins,
only vitamin E is already known to generate 1O2 via excitation
at 308 nm.20 The reported quantum yield was 0.17 ± 0.025 in
methanol, which is in good correlation with our experiments
(0.15 ± 0.02, Table 1).
Our values of quantum yields diﬀer for PYR, PYR-5-PH,
PYRXAL-HCL, and PYR-HCL, when compared to Dzhagarov
et al. (Table 1).41 However, we learnt from our setting used pre-
viously23 that the power stability of the exciting UVB source
during 1O2 detection is extremely critical for the accuracy of
1O2 quantum yield. Our laser system oﬀers an excellent stabi-
lity of optical power of less than 3.5% fluctuation during 1O2
detection.
Quantum yield of 1O2 generation using diﬀerent UVA
wavelengths
UVA1 phototherapy (wavelength: 340–400 nm) has become a
new physical therapy in recent years, which is eﬀective in the
Table 1 The 1O2 quantum yield ΦΔ of endogenous photosensitizers at diﬀerent UV wavelengths
Endogenous
photosensitizers
UVB UVA2 UVA1 Literature
values308 nm 330 nm 370 nm
FAD 0.13 ± 0.03 0.12 ± 0.03 0.15 ± 0.03 0.07 ± 0.01d 28
FMN 0.58 ± 0.06 0.64 ± 0.07 0.58 ± 0.06 0.51 ± 0.07d 28
Riboflavin 0.61 ± 0.07 0.64 ± 0.07 0.58 ± 0.06 0.54 ± 0.07d 28
0.40 ± 0.10e 23
PYR-5-PH 0.16 ± 0.03 0.13 ± 0.03 0.14 ± 0.03 0.54 ± 0.06c 41
PYRXAL-HCL 0.06 ± 0.02 0.08 ± 0.02 —a 0.44 ± 0.06c 36
PYRINE-DHCL 0.06 ± 0.02 0.04 ± 0.01 —a 0.06 ± 0.02c 41
PYR-HCL 0.07 ± 0.02 0.05 ± 0.02 —a 0.28 ± 0.04c 41
0.10 ± 0.05e 23
PYR 0.11 ± 0.03 0.08 ± 0.02 —a 0.28 ± 0.04c 41
Nicotinic acid f 0.05 ± 0.01 —a —a 0.05 ± 0.05e 23
Nicotinic acid amide f 0.64 ± 0.07 —a —a —b
Vitamin A 0.06 ± 0.02 — — 0.05d 55
Vitamin D2 0.02 ± 0.01 —
a —a —b
Vitamin D3 0.007 ± 0.005 —
a —a —b
Vitamin E 0.15 ± 0.02 —a —a 0.085 ± 0.005e 20
0.17 ± 0.025e 20
Vitamin K1 0.02 ± 0.01 — — —
b
a Absorption of radiation at the respective wavelength was too low. bNo literature values available. c Vitamins of the B6 group without residual.
d Excitation at 355 nm. eUVB excitation. fDissolved in D2O.
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treatment of scleroderma and other connective tissue dis-
eases.42 UVA1 damage to critical biomolecules such as DNA
has been widely attributed to its ability to generate reactive
oxygen species via endogenous photosensitizers.43 However,
UVA radiation was as eﬀective as solar simulated UV
(290–400 nm) in suppressing the elicitation of an established
immune response, whereas irradiation with UVA1 had no
eﬀect.44 Other experiments showed that a specific spectrum,
which contained UVB and UVA2 (290–325 nm), augments the
formation of melanocytic nevi in a guinea-pig model for
human nevi.45 It was proved that the solar-UV-signature
mutation in mouse skin is commonly observed in the
wavelength range from UVB to UVA, and that UVA1 induced
the mutation more preferentially than the other shorter
wavelength ranges.5 It was recently shown, both in vivo and
in vitro, that UVA1 radiation suppresses calcineurin activity
and that this activity loss is due to singlet oxygen and
superoxide generated by photosensitized reactions. 1O2
obviously plays a certain role in these UVA1 or UVA2 medi-
ated processes and the vitamins are potential endogenous
photosensitizers.
However, these diﬀerent findings might lead to the sugges-
tion that diﬀerent UVA wavelengths might yield diﬀerent
quantum yields of 1O2 generation. The values of ΦΔ were
already determined for some vitamins when using either
broadband UVA radiation (320–400 nm) or monochromatic
UVA laser excitation with usually 355 nm.10 Now, our endo-
genous photosensitizers were exposed to wavelengths of
either UVA1 (320–340 nm) or UVA2 (340–400 nm) to check
diﬀerences of 1O2 generation. We measured the values of ΦΔ
in the UVA1 and UVA2 range by exciting the vitamins in solu-
tion at 330 nm (UVA2) or 370 nm (UVA1) provided that the
respective vitamin molecule showed suﬃcient absorption at
these wavelengths. The quantum yield ΦΔ could be detected
for FAD, FMN, riboflavin and PYR-5-PH in both UVA ranges
(Table 1). Due to the absorption coeﬃcient of PYRXAL-HCL,
PYRINE-DHCL, PYR-HCL and PYR, the values could be
detected for the excitation with UVA2 only (Table 1). The vita-
mins of the B-group contribute to UVA induced 1O2 generation,
whereas the eﬀect is restricted for some of them to UVA2 radi-
ation due to their absorption spectra.
When taking the values of ΦΔ for UVA1, UVA2, and even
UVB into account, the choice of excitation wavelength seems to
play no role within experimental accuracy. Whether these vita-
mins generate 1O2 depends obviously on their ability to absorb
the respective radiation. The values of ΦΔ are in line with the
values found in the literature for FMN, FAD, riboflavin, vita-
mins A and E. However, our values for the vitamin B6 mole-
cules are constantly smaller (≤0.16) as compared to the work
of Dzhagarov et al., except for PYRINE-DHCL. One other possi-
ble explanation could be the method of estimating the ΦΔ
value by comparing with a reference substance. Dzhagarov
et al. used the maximal amplitude of the luminescence signal
as luminescence energy. In our experiments, all detected lumi-
nescence photons of the luminescence signal were summed
up to calculate ΦΔ. This procedure considers also the
shortened luminescence decay times of B6 vitamins and might
avoid an overestimation of ΦΔ values.
Photostability
Absorption of radiation by an endogenous photosensitizer
such as vitamins and its ability to produce 1O2 are very sensi-
tive to the respective molecular structure. Any change of that
structure can immediately and substantially change absorp-
tion and 1O2 production. Energy-rich UV radiation can change
the structure of photosensitizer molecules depending on the
wavelength and the energy applied. These changes, in particu-
lar during continuous, long-lasting irradiation, should aﬀect
the role of endogenous photosensitizers and its impact on
cellular damage. It is already known that UV radiation can
lead to photochemical decomposition of vitamin molecules
such as α and γ tocopherol,46,47 vitamin A,48,49 vitamin K1,50
and vitamin B.51,52
Therefore, the absorption spectra of the vitamins were
recorded after UVB irradiation at 1 J cm−2 using a UVB lamp
showing an emission maximum at 312 nm (Fig. 4, red line).
This radiant exposure equals roughly the daily radiant
exposure of UVB in Potsdam, Germany.53 The mean UVB
intensity used for estimating 1O2 quantum yields at 308 nm is
0.45 ± 0.05 J cm−2. Absorption spectroscopy showed that the
UVB irradiation of the vitamins changed the absorption spec-
trum in diﬀerent ways, partially in the entire UV range
(280–400 nm). For example, UVB and UVA absorption of
PYR-HCL decreased, but increased for vitamin K1 (Fig. 4). In
the case of PYR-5-PH, the absorption in the UVB region
increased, but decreased in the UVA range, and the other way
around for vitamin E (Fig. 4).
For all vitamins the absorption spectra before (Fig. 4, blue
line) and after (Fig. 4, red line) irradiation with 1 J cm−2 were
measured and analyzed. The diﬀerence in absorption at
308 nm in the UVB and at 355 nm in the UVA region before
and after irradiation is shown for all vitamins (Table 2). Also
the integral of the whole absorption in the UVB (280–320 nm)
and in the UVA (320–400 nm) region was calculated before and
after the irradiation and compared with each other (Table 2).
For nearly all vitamins a clear diﬀerence in absorption at least
in the UVA or UVB region after UVB irradiation could be
detected. Only the absorption spectra of FMN showed no
diﬀerence after the UVB irradiation (1 J cm−2) within the
experimental accuracy.
1O2 generation of UVB pre-irradiated vitamins
These altered molecules might show diﬀerent photophysical
features. Exemplarily, the 1O2 generation of the lipophilic
vitamin E and vitamin K1 before and after UVB pre-irradiation
was investigated for an excitation wavelength of 308 and
355 nm. Vitamin E shows UVA absorption close to zero before
UVB pre-irradiation at 355 nm. Vitamin K1 shows high absorp-
tion in the UVA range but a very low singlet oxygen quantum
yield (0.02 ± 0.01). Therefore, vitamin E and vitamin K1
without pre-irradiation showed a very low 1O2 luminescence
signal when excited with UVA radiation.
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However, when vitamin E was exposed to 1 J cm−2 UVB
radiation, the absorption value at 355 nm increased from 1 to
15%. After that, vitamin E was excited with 355 nm laser radi-
ation and the spectrally resolved luminescence signal clearly
showed 1O2 generation (Fig. 5) with ΦΔ = 0.05 ± 0.01. However,
this value is smaller than for excitation with UVB at 308 nm
(0.15 ± 0.02, Table 1).
The absorption of vitamin K1 at 355 nm increased for
irradiation with 1 J cm−2 UVB radiation from 28% to 38%
(Table 2). Comparable to experiments with vitamin E, pre-
irradiation of vitamin K1 with UVB led to
1O2 generation when
excited with 355 nm (Fig. 4). The corresponding value of ΦΔ
increased from 0.02 ± 0.01 (Table 1) to 0.10 ± 0.02.
The absorption of vitamin E and K1 also increased at
308 nm after irradiation with 1 J cm−2 UVB radiation (Table 2).
The spectrally resolved singlet oxygen luminescence signal of
vitamin K1 via UVB excitation (308 nm) also increased after
pre-irradiation with 1 J cm−2 UVB radiation (Fig. 5). The
corresponding value of ΦΔ increased from 0.02 ± 0.01 (Table 1)
to 0.10 ± 0.02 just as for excitation at 355 nm. For vitamin E
the spectrally resolved singlet oxygen signal decreased for an
excitation at 308 nm after UVB pre-irradiation, which is in line
with a decreased singlet oxygen quantum yield ΦΔ of 0.05 ± 0.01.
These data provide evidence that irradiation of vitamins
with UVB can change the photophysical features of these
endogenous photosensitizers, leading to a change of their
potential to generate 1O2 when exposed to UVB or UVA radi-
ation. Thus, UVB photosensitizers like vitamin E also become
endogenous photosensitizers for UVA radiation after exposure
to UVB.
Fig. 4 The changes of the absorption spectra of all investigated vitamins after irradiation with 1 J cm−2 UVB (red line) are shown. The blue line rep-
resents the original absorption spectra of each molecule.
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This eﬀect should play a major role in all experimental set-
tings in which UVA and UVB were consecutively applied to
cells or tissue to detect any signaling or damaging eﬀects.54
These changes may even occur under parallel application of
UVA and UVB radiation as for experiments with solar simu-
lators or exposure to natural solar radiation. In addition, such
photochemical changes of endogenous photosensitizers along
with the ability to generate 1O2 may aﬀect the interpretation of
results regarding the role of UVA and UVB in skin damaging
eﬀects in vivo.
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Fig. 5 On the left side, the spectral-resolved 1O2 signal of 250 µM vitamin E in ethanol is shown for UVB (308 nm, top) or UVA excitation (355 nm,
bottom) before (blue line) and after (red line) pre-irradiation with a UVB radiant exposure of 1 J cm−2. The maximum is ﬁtted between 1270 and
1275 nm. The charts on the right side show the corresponding results for spectral-resolved 1O2 signal of 100 µM vitamin K1 in ethanol.
Table 2 The changes of the absorption of endogenous vitamins before and after irradiation with 1 J cm−2 UVBa
Substance
UVB (308 nm)
absorption [%]
UVA (355 nm)
absorption [%]
Total UVB absorption
(280–320 nm)
Total UVA absorption
(320–400 nm)
Before After Before After After After
FAD (150 µM) 26 32 88 89 +8% +2%
FMN (100 µM) 21 21 83 82 Unchanged Unchanged
Riboflavin (100 µM) 23 24 84 85 +3% +2%
Nicotinic acid amide (30 mM) 18 18 1 1 Unchanged +4%
Nicotinic acid (30 mM) 42 44 0 2 +1% +93%
PYR-5-PH (200 µM) 43 61 67 17 +50% −69%
PYRXAL-HCL (100 µM) 83 32 2 9 −41% −47%
PYRINE-DHCL (100 µM) 65 24 9 6 −51% −62%
PYR-HCL (100 µM) 65 21 6 4 −58% −70%
PYR (100 µM) 66 19 8 5 −60% −70%
Vitamin A (25 µM) 45 37 82 61 −8% −26%
Vitamin D2 (250 µM) 44 31 1 5 −20% +448%
Vitamin D3 (250 µM) 40 23 0 0 −28% −100%
Vitamin E (250 µM) 25 31 1 15 −11% +1047%
Vitamin K1 38 63 29 38 +93% +66%
a An increase or decrease in absorption (≥2% for absorption at 308 or 355 nm) is indicated with bold numbers. The total absorption was
calculated by summing up all absorption values in the spectral range (280–320 and 320–400 nm) before and after irradiation. The change in
absorption after UVB pre-irradiation is given in %.
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